British Journal of Anaesthesia, Vol 82, Issue 1 41-46, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia
J. S. Noble, A. M. Reid, LVM. Jordan, ACA. Glen and JAH. Davidson
Cardiac troponin I (cTnI) is a protein that is specific to heart muscle.
Increased concentrations appear in serum after myocardial cell injury. cTnI
was compared with creatinine kinase MB (CK MB), myoglobin and the 12-lead
ECG for detection of myocardial injury in an unselected series of 109
medical and surgical ICU patients. Clinical observations and daily 12-lead
ECG were recorded prospectively. Samples for cTnI, myoglobin and CK MB
serum analysis were collected each day. Increased serum cTnI concentrations
(> 0.1 microgram litre-1) were observed in 70.6% (n = 77) of the ICU
group. Tachycardia, arrhythmia, hypotension and treatment with inotropic
drugs were associated with higher concentrations. The standardized
mortality ratio by APACHE III for the ICU sample was 0.98. All subjects in
an unmatched control group of 98 medical unit emergency admissions without
a primary cardiac diagnosis had serum cTnI concentrations < 0.1
microgram litre-1. We conclude that increased serum cTnI concentrations
occur frequently in the ICU suggesting that there is a high incidence of
cardiac injury in these patients.
CLINICAL INVESTIGATIONS
Troponin I and myocardial injury in the ICU
Department of Anaesthesia, Victoria Infirmary, Langside Road, Glasgow, G42 9TY, UK; Department of Clinical Chemistry, Victoria Infirmary, Langside Road, Glasgow, G42 9TY, UK
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Lim, I. Qushmaq, P. J. Devereaux, D. Heels-Ansdell, F. Lauzier, A. S. Ismaila, M. A. Crowther, and D. J. Cook Elevated Cardiac Troponin Measurements in Critically Ill Patients Arch Intern Med, December 11, 2006; 166(22): 2446 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Codispoti, T. Sundaramoorthi, R. A. Saad, A. Reid, C. Sinclair, and P. Mankad Optimal myocardial protection strategy for coronary artery bypass grafting without cardioplegia: prospective randomised trial Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 217 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lim, D. J. Cook, L. E. Griffith, M. A. Crowther, and P. J. Devereaux Elevated Cardiac Troponin Levels in Critically Ill Patients: Prevalence, Incidence, and Outcomes Am. J. Crit. Care., May 1, 2006; 15(3): 280 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Minkin, D. Cotiga, S. Noack, A. Dobrescu, P. Homel, and J. M. Shapiro Use of Admission Troponin in Critically Ill Medical Patients J Intensive Care Med, December 1, 2005; 20(6): 286 - 290. [Abstract] [PDF] |
||||
![]() |
J.-P. Quenot, G. Le Teuff, C. Quantin, J.-M. Doise, M. Abrahamowicz, D. Masson, and B. Blettery Myocardial Injury in Critically Ill Patients: Relation to Increased Cardiac Troponin I and Hospital Mortality Chest, October 1, 2005; 128(4): 2758 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bruemmer-Smith, M. S. Avidan, B. Harris, S. Sudan, R. Sherwood, J. B. Desai, F. Sutherland, and J. Ponte Glucose, insulin and potassium for heart protection during cardiac surgery Br. J. Anaesth., April 1, 2002; 88(4): 489 - 495. [Abstract] [Full Text] [PDF] |
||||





